Status:

COMPLETED

Decision Support System to Evaluate VENTilation in ARDS

Lead Sponsor:

Imperial College London

Collaborating Sponsors:

European Commission

Mermaid A/C

Conditions:

Acute Respiratory Distress Syndrome

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Patients with Acute Respiratory Distress Syndrome (ARDS) residing in the intensive care unit (ICU) often require support for their breathing from a mechanical ventilator to provide adequate gas exchan...

Detailed Description

The study is a randomised control trial, comparing the effects of mechanical ventilation in ARDS provided as standard care, with mechanical ventilation set according to the advice of the Beacon Care s...

Eligibility Criteria

Inclusion

  • Invasive mechanical ventilation.
  • Within 1 week of a known clinical insult or new or worsening respiratory symptoms
  • Chest radiograph with bilateral infiltrates consistent with evidence of pulmonary oedema but not fully explained by cardiac failure.
  • Hypoxaemia as defined by PaO2/FiO2 of ≤ 300mmHg (or ≤ 40kPa) (pre-ECMO PaO2/FiO2 will be used should patient be placed on extracorporeal support).

Exclusion

  • Age \< 18 years old.
  • The absence of an arterial catheter for blood sampling at study start.
  • Consent declined.
  • Over 7 days of mechanical ventilation.
  • Treatment withdrawal imminent within 24 hours.
  • DNAR (Do Not Attempt Resuscitation) order in place
  • Severe chronic respiratory disease requiring domiciliary ventilation (except for sleep disordered breathing)
  • Veno-Arterial ECMO
  • Healthy Volunteer Sample collection:
  • Inclusion Criteria
  • 18 years or older
  • Able to consent
  • Have mental capacity
  • Exclusion Criteria
  • Blood borne viruses: HIV, Hep B, Hep C
  • Blood taken in the last 7 days
  • Under doctor for investigation
  • Haematological disease
  • Currently suffers from infection
  • Needle phobia
  • Problems with veins / vessels
  • Refusal

Key Trial Info

Start Date :

March 19 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 30 2021

Estimated Enrollment :

95 Patients enrolled

Trial Details

Trial ID

NCT04115709

Start Date

March 19 2020

End Date

August 30 2021

Last Update

September 16 2021

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Medical University of Vienna

Vienna, Waehringer Guertel, Austria, A-1090

2

Université Clermont Auvergne

Clermont-Ferrand, France, 63003

3

Imperial College London, Royal Brompton Hospital campus

London, United Kingdom, SW3 6NP